Related by context. Frequent words. (Click for all words.) 78 Key Milestones 71 Patient Enrollment 67 Milestone Payment 67 Prostate Cancer Patients 67 Continues Momentum 66 Positive Cash Flow 66 Fifth Consecutive Year 66 Epilepsy Drug 66 Flagship Product 65 Internationally Recognized 65 Achieves Milestone 65 Successful Launch 65 Annual Meeting Date 65 Fifth Consecutive 65 Meets Primary Endpoint 65 Sixth Consecutive Year 64 Opns 64 Momentum Continues 64 Successful Completion 64 Profitable Quarter 64 Exponential Growth 64 Japanese Stocks Climb 64 Phase III Clinical Trial 64 Improves Survival 64 Third Quarter Dividend 64 Stock Buyback Program 64 Single Dose 64 Slowest Pace 64 RNAi Therapeutics 64 Ninth Consecutive 64 Cervical Cancer Vaccine 64 Consecutive Years 64 Surgical Procedures 64 Helps Organizations 63 Worker Productivity 63 Lifts FY# Outlook 63 Explosive Growth 63 Strengthens Leadership 63 Operational Efficiencies 63 Expands Portfolio 63 Distribution Agreements 63 Preclinical Data 63 Seamless Integration 63 Partner Ecosystem 63 Previously Announced 63 StockSource.us Reports 63 Multimillion Dollar 62 Productivity Gains 62 Malaria Vaccine 62 Million Downloads 62 Bought Deal Financing 62 FDA Clears 62 Secures Financing 62 Double Digit Growth 62 Increases Productivity 62 Mechel Announces 62 Contracts Totaling 62 Contracts Worth 62 Madrid Bombings 62 Develop Novel 62 Osteoporosis Drug 62 Multi Billion Dollar 62 Provides Shareholder 62 Drug Candidate 62 Cholesterol Drug 62 Clinical Trial Results 62 Share Buyback Program 62 Inhaled Insulin 61 Bankrate Mortgage Rates 61 Record Third Quarter 61 Develop Next Generation 61 Arthritis Drug 61 Record Second Quarter 61 Significantly Improved 61 Cancer Stem Cells 61 Accelerate Growth 61 Prostate Cancer Treatment 61 Jobless Claims Fall 61 Lung Cancer Patients 61 Expansion Continues 61 STRATEGY ANALYTICS 61 Phase III Trial 61 Grants Awarded 61 Announces FDA Clearance 61 Closes Financing 61 Receives Orphan Drug Designation 61 Cancer Treatments 61 Final Stages 61 Newest Version 61 FDA Accepts 61 FY# Guidance 61 Store Openings 61 Jobless Claims Drop 61 Builds Momentum 61 Second Quarter Dividend 61 Diagnostic Tests 61 Survival Rates 61 Share Repurchase Authorization 61 Product Lineup 61 Complete Merger 61 By MARK TODD